Roche Holding AG

RHHVF · SWISS

$475.00+$16.91 (+3.69%)TodayMarket closed · Oct 20, 3:58 PM ET

Prev close $458.09

About RHHVF

Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 112,774 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Employees: 112,774
Headquarters: Basel, Basel-Stadt
Listed: May 4, 2001
Sector: Health Care
Industry: Pharmaceuticals
Website: roche.com

Leadership

Roche Holding AG executives
Name	Title	Since	Age
Severin Schwan	—	2006	58
Thomas Schinecker	—	—	50
Andre Hoffmann	—	—	65
Alan Hippe	—	—	58
Teresa Graham	—	—	52
Matt Sause	—	—	48
Cristina Wilbur	—	—	58
Wafaa Mamilli	—	—	57
Pascale Schmidt	—	—	52
Claudia Boeckstiegel	—	—	61
Levi Garraway	—	—	57
Silke Hoernstein	—	—	50
Aviv Regev	—	—	54
Barbara Schaedler	—	—	63
Boris Zaitra	—	—	53
Per-Olof Attinger	—	—	65
Joerg Duschmale	—	—	41
Claudia Dyckerhoff	—	—	58
Patrick Frost	—	—	57
Anita Hauser	—	—	56
Prof. Dr. Akiko Iwasaki	—	—	55
Prof. Dr. Richard Lifton	—	—	72
Jemilah Mahmood	—	—	66
Mark Schneider	—	—	60
Loren Kalm	—	2022	—

Similar companies

Companies in the same industry as Roche Holding AG

OCSOculis Holding AG$7.49+2.32%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.